|
1. M. Gumbleton and W. Sneader, Pharmacokineticconsiderations in rational drug design. Clin. Pharmacokinet., 26, 161 - 168 (1994). 2. M. J. Humphrey and D. A. Smith, Role of metabolism and Pharmacokineticstudies in the discovery of new drugs - present and future perspectives. Xenobiotica, 22, 743 - 755 (1992). 3. J. M. Fromsen, Perspectives in pharmacokinetics: A phased approach to drug development. J. Pharmacokinet. Biopharm., 17, 509 - 521 (1989). 4. Y. Kimura, H. Okuda, T. Okuda, T. Hatano, I. Agata and S. Arichi: Studies on the activities of tannins and related compounds from medicinal plants and drugs. VI. Inhibitory effects of caffeoylquinic acids on histamine release from rat peritoneal mast cells; Chem. Pharm. Bull., 33, 690-696 (1985). 5. Y. Kimura, H. Okuda, T. Okuda, T. Hatano, I. Agata and S. Arichi, Studies on the activities of tannins and related compounds from medicinal plants and drugs. VII. effects of extracts of leaves of artemisia species, and caffeic acid and chlorogenic acid on lipid metabolic injury in rats fed peroxidized oil. Chem. Pharm. Bull., 33, 2028 - 2034 (1985). 6. T. Okuyama, S. Shibata, M. Hoson, T. Kawada, H. Osada and T. Noguchi: Effects of oriental plant drugs on platelet aggregation; III. Effects of chinese drug "Xiebai" on human platelet aggregation; Planta Med., 52: 171-175 (1986). 7. T. Hatano, T. Yasuhara, R. Yoshihara, I. Agata, T. Noro and T. Okuda, Effects of interaction of tannins with co-existing substance. VII. Inhibitory effects of tannins and related polyphenols on xanthine oxidase. Chem. Pharm. Bull., 38, 1224-1229 (1990). 8. M.-T. Huang, R. C. Smart, C.-Q. Wong and A. H. Conney, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-o-tetradecanoylphorbol-13-acetate. Cancer Res., 48, 5941-5946 (1988). 9. W.-C. Chang and F.-L. Hsu, Inhibition of platelet activation and endothelial cell injury by polyphenolic compounds isolated from Lonicera japonica Thumb. Pg. Lt. Essen. fatty acid, 45, 307-312 (1992). 10. R. Ficarra, P. Ficarra, S. Tommasini, ML. Calabro, S. Ragusa, R. Barbera and A. Rapisarda, Leaf extracts of some Cordia species: analgesic and anti-inflammatory activities as well as their chromatographic analysis. Farmaco., 50, 245-56 (1995). 11. O. S. Sohn, A. Surace, E. S. Fiala, J. P. Richie Jr., S. Colosimo, E. Zang and J. H. Weisburger, Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica, 24, 119-127 (1994). 12. S. G. Khan, S. K. Katiyar, R. Agarwal and H. Mukhtar, Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res., 52, 4050-4052 (1992). 13. S. K. Katiyar, R. Agarwal, M. T. Zain and H. Mukhtar, Protection against N-nitrosodiethylamine and benzo[a]pyrene induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis, 14, 849-855 (1993). 14. A. L. Blum, W. Doelle, K. Kortum, P. Peter, G. Strohmeyer, P. Berthet, H. Goebell, S. Pelloni, H. Poulsen and N. Tygstrup, Treatment of acute viral hepatitis wit (+)-cyanidanol-3, Lancet, 3, 1153-1155 (1977). 15. P. Morazzoni, A. Montalbetti, S. Malandrino and G. Pifferi, Comparative pharmacokinetics of silipide and silymarin in rats. Eur. J Drug Metab. Pharmacokinet., 18, 289-297 (1993). 16. R. Weyhenmeyer, H. Mascher and J. Birkmayer, Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. Int. J Clin. Pharmacol. Ther. Toxicol., 30, 134-138 (1992). 17. N. P. Das, Studies on flavonoid metabolism, absorption and metabolism of (+)-catechin in man, Biochem. Pharmacol., 20, 3435-3445 (1971). 1. 李岳霖, Pharmacokinetic study of (+)-catechin in rabbits. Master thesis (1994). 19. Y. Kimura and H. Okuda, Studies on the activities of tannins and related compounds, X. Effects of caffeetannins and related compounds on arachidonate metabolism in human polymorphonuclear leukocytes. J. Natural Products, 50, 392-399 (1987). 20. Y. Koshihara, T. Neichi, S. Murota, A. Lao, Y. Fujimoto, T. Tatsuno, Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochimica et Biophysica Acta, 792, 92-97 (1984). 21. C. G. Fraga, V. S. Martino, G. E. Ferraro, J. D. Coussio and A. Boveris, Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem. Pharmacol., 36, 717-720 (1987). 22. P. Basnet, K. Matsushige, K. Hase, S. Kadota and T. Namba, Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol. Pharm. Bull., 19, 1479-1484 (1996 ). 23. V. Perez-Alvarez, R. A. Bobadilla-Lugo, P. Muriel, L. Favari and C. Villanueva-Lopez, Effects of leukotriene synthesis inhibition on acute liver damage induced by carbon tetrachloride. Pharmacol., 47, 330-336 (1993). 24. W. -S. Chang, Y. -H. Chang, F. -J. Lu and H. -C. Chiang, Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res., 14, 501-506 (1994). 25. Y. Kono, K. Kobayashi, S. Tagawa, K. Adachi, A. Ueda, Y. Sawa and H. Shibata, Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim. et Biophy. Acta. 1335, 335-42 (1997). 26. M. Nardini, M. D''Aquino, G. Tomassi, V. Gentili, M. Di Felice and C. Scaccini, Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Rad. Biol. Med., 19, 541-52 (1995). 27. J. A. Laranjinha, O. Vieira, V. Madeira and L. M. Almeida, Two related phenolic antioxidants with opposite effects on vitamin E content in low density lipoproteins oxidized by ferrylmyoglobin: consumption vs regeneration. Arch. Biochem. Biophy. 323, 373-81 (1995). 28. J. A. Laranjinha, L. M. Almeida and V. M. Madeira, Reactivity of dietary phenolic acids with peroxyl radicals: antioxidant activity upon low density lipoprotein peroxidation. Biochem. Pharm., 48, 487-94 (1994). 29. S. Toda, M. Kumura and M. Ohnishi, Effects of phenolcarboxylic acids on superoxide anion and lipid peroxidation induced by superoxide anion. Planta Med., 57, 8-10 (1991). 30. M. -T. Huang, R. C. Smart, C. -Q. Wong and A. H. Conney, Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-o-tetradecanoylphorbol-13-acetate. Cancer Res., 48, 5941-5946 (1988). 31. R. H. San and R. I. Chan, Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis. Mut. Res., 177, 229-39 (1987). 32. V. S. Aboobaker, A. D. Balgi and R. K. Bhattacharya, In vivo effect of dietary factors on the molecular action of aflatoxin B1: role of non-nutrient phenolic compounds on the catalytic activity of liver fractions, In Vivo, 8, 1095-1098 (1994). 33. A. J. Alldrick, J. Flynn and I. R. Rowland, Effects of plant-derived flavonoids and polyphenolic acids on the activity of mutagens from cooked food. Mut. Res., 163, 225-32, 1986. 34. L. W. Wattenberg, J. B. Coccia and L. K. Lam, Inhibitory effects of phenolic compounds on benzo(a)pyrene-induced neoplasia. Cancer Res., 40, 2820-2823 (1980). 35. J. Alanko, A. Riutta, H. Vapaatalo and I. Mucha, Catecholamines decrease leukotriene B4 and increase thromboxane B2 synthesis in A23187-stimulated human whole blood. Prostaglandins, 42, 279-87 (1991). 36. Y. F. Chen, H. Y. Tsai and T. S. Wu, Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Med., 61, 2-8 (1995). 37. M. A. Rosei, Inhibition of Dopa decarboxylase by caffeic acid and related compounds: structure-activity relationships. Pharm. Res. Comm., 19, 663-671 (1987). 38. Y. Kumada, H. Naganawa, H. Iinuma, M. Matsuzaki and T. Takeuchi, Dehydrodicaffeic acid dilactone, an inhibitor of catechol-O-methyl transferase. J. Antibiot., 29, 882-889 (1976). 39. E. Strehl, R. Volpert and E. F. Elstner, Biochemical activities of propolis-extracts. III. Inhibition of dihydrofolate reductase. J. Biosci., 49, 39-43 (1994). 40. M. M. Manson, H. W. Ball, M. C. Barrett, H. L. Clark, D. J. Judah, G. Williamson and G. E. Neal, Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogen., 18, 1729-1738 (1997). 41. D. D. Kitts and A. N. Wijewickreme, Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme systems. Plant Foods Human Nut., 45, 287-298 (1994). 42. M. John, H. G. Gumbinger and H. Winterhoff, Oxidation products of caffeic acid as model substances for the antigonadotropic activity of plant extracts. Planta Med., 56, 14-18 (1990). 43. A. Nahrstedt, M. Albrecht, V. Wray, H. G. Gumbinger, M. John, H. Winterhoff and F. H. Kemper, Structures of compounds with antigonadotropic activity obtained by in vitro oxidation of caffeic acid. Planta Med., 56 395 - 398 (1990). 44. H. Cho, M. Ueda, M. Tamaoka, M. Hamaguchi, K. Aisaka, Y. Kiso, T. Inoue, R. Ogino, T. Tatsuoka, T. Ishihara, T. Nagachi, I. Morita and S. Murota, Caffeic acid derivatives: Extremely potent inhibitors of 12-lipoxygenase. J. Med. Chem., 34, 1503-1505 (1991). 45. S. Inayama, K. Harimaya, H. Hori, T. Ohkura, T. Kawamata, M. Hikichi and T. Yokokura, Studies on non-sequiterpenoid constituents of Gaillardia pulchella. II. Less lipophilic substances, methyl caffeate as an antitumor catecholic, Chem. Pharm. Bull,. 32, 1135-1141 (1984). 46. M. Amoros, E. Lurton, J. Boustie, L. Girre, F. Sauvager and M. Cormier, Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. J. Nat. Products, 57, 644-7 (1994). 47. K. Frenkel, H. Wei, R. Ye J. Bhimani, J. A. Zadunaisky, M. T. Huang, T. Ferraro, A. H. Conney and D. Grunberger, Inhibition of tumor promoter-mediated processes in mouse skin and bovine lens by caffeic acid phenethyl ester. Cancer Res., 53, 1255-1261 (1993). 48. I. Saracoglu, M. Inoue, I. Calis and Y. Ogihara, Studies on constituents with cytotoxic and cytostatic activity of two Turkish medicinal plants Phlomis armeniaca and Scutellaria salviifolia. Biol. Pharm. Bull., 18, 1396-1400 (1995). 49. A. K. Jaiswal, R. Venugopal, J. Mucha, A. M. Carothers and D. Grunberger, Caffeic acid phenethyl ester stimulates human antioxidant response element-mediated expression of the NAD(P)H:quinone oxidoreductase (NQO1) gene. Cancer Res., 57, 440-446 (1997). 50. M. R. Fesen, Y. Pommier, F. Leteurtre, S. Hiroguchi, J. Yung and K. W. Kohn, Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol., 48, 595-608 (1994). 51. A. Mazumder, S. Wang, N. Neamati, M. Nicklaus, S. Sunder, J. Chen, G. W. Milne, W. G. Rice, T. R. Burke Jr. and Y. Pommier, Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. J. Med. Chem., 39, 2472-2481 (1996). 52. T. R. Burke Jr. M. R. Fesen, A. Mazumder, J. Wang, A. M. Carothers, D. Grunberger, J. Driscoll, K. Kohn and Y. Pommier Y, Hydroxylated aromatic inhibitors of HIV-1 integrase. J. Med. Chem., 38, 4171-4178 (1995). 53. E. Sondheimer, On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch. Biochem. Biophys., 74, 1131-1138 (1958). 54. E. Haslam, Plant polyphenols: vegetable tannins revisited; Cambridge university press, New York, pp 16, 1989. 55. V. A. Fung, T. P. Cameron, T. J. Hughes, P. E. Kirby and V. C. Dunkel: Mutagenic activity of some coffee flavor ingredients; Mutation Research, 204, 219-228 (1988). 56. H.Y. Hsu, Y.P. Chen and M. Hang: The chemical constituents of oriental herbs Vol. I , Oriental Healing Arts Institute, Taipei, pp 264, 1982. 57. S. Budavari: The Merck Index: an encyclopedia of chemicals, drugs, and biologicals, 11th ed. Merck & Co., Inc. press, New Jersey; pp 248, 1989. 58. M. John, H. G. Gumbinger and H. Winterhoff, Oxidation products of caffeic acid as model substances for the antigonadotropic activity of plant extracts. Planta Med., 56, 14-18 (1990). 59. J. J. L. Cilliers and V. L. Singleton, Characterization of the products of nonenzymic autoxidative phenolic reactions in a caffeic acid model system. J. Agric. Food Chem., 39, 1298-1303 (1991). 60. J. J. L. Cilliers and V. L. Singleton, Nonenzymic autoxidative phenolic browning reactions in a caffeic acid model system. J. Agric. Food Chem., 37, 890-896 (1989). 61. J. J. L. Cilliers and V. L. Singleton, Caffeic acid autoxidation and the effects of thiols. J. Agric. Food Chem., 38, 1789-1796 (1990). 1. 康鳳蓮, Pharmacokinetic study of caffeic acid and its ester in rabbits. Master thesis (1994). 63. Y.-S. Uang, F.-L. Kang and K.-Y. Hsu, Determination of caffeic acid in rabbit plasma by high-performance liquid chromatography. J. Chromatogr. B, 673, 43-49 (1995). 64. J. Westendorf and G. Czok, Studies on the pharmacokinetics of C-14 cinnamic-acid derivatives in rats. Zeitschrift fur Ernahrungswissenschaft, 17, 26-36 (1978). 65. J. Westendorf and G. Czok, Biliary excretion of choleretically active cinnamic acid derivatives in the rat. Zeitschrift fur Ernahrungswissenschaft, 22, 255-270 (1983). 66. H. G. Gumbinger, U. Vahlensieck and H. Winterhoff, Metabolism of caffeic acid in the isolated perfused rat liver. Planta Med., 59, 491-493 (1993). 67. J. Camarasa, E. Escubedo and T. Adzet, Pharmacokinetics of caffeic acid in rats by a high-performanceliquid chromatography method. J. Pharm. Biomed. Anal., 6, 503-510 (1988). 68. C. Shumaker, Pkcalc: a basic interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab. Rev., 17, 331-348 (1986). 69. M. Metzier and D. L. Weiner, PCNONLIN User Guide, Version 4.0, Statistical Consultants Inc., KY, 1992. 70. K. Yamaoka, T. Nakagawa and T. Uno, Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokin. Biopharm., 6, 165-175 (1978). 71. A. Deslandes, J. F. Westphal,, J. H. Trouvin and R. Farinotti, Adaptive computer program for determination of absorption profiles by numericcal deconvolution: application to amoxicillin absorption. J. Pharm. Sci., 81, 802-807 (1992). 72. M. Gibaldi and D. Perrie, Pharmacokinetics, Dekker, New York, 1982, pp.45-88. 73. J. H. Zar, Biostatistical analysis, 2nd ed., Prentice Hall, New Jersey, 1984, pp 206-235. 74. J. Kawakami, Y. Yamamura, T. Santa, H. Kotaki, K. Uchino, Y. Sawada and T. Iga, Kinetic analysis of Glycyrrhetic acid, an active metabolite of Glycyrrhizin, in rats: Role of enterohepatic circulation. J. Pharm. Sci., 82, 301-305 (1993). 75. R. L. Oberle and G. L. Amidon, The inference of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine. J. Pharmacokinet. Biopharm., 15, 529 — 545 (1987). 76. M. F. Williams, G. E. Dukes, W. Heizer, Y. —H. Han, D. J. Hermann, T. Lampkin and L. J. Hak, Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine. Pharm. Res., 9, 1190 —1194 (1992). 77. Y. -H. Yeom, R. P. Remmel, S.-H. Huang, M. Hua, R. Vince and C. L. Zimmerman, Pharmacokinetics and bioavailability of carbovir, a carbocyclic nucleoside active against human immunodeficiency virus, in rats. Antimicrob. Agents Chemother., 33, 171-175 (1989). 78. A. B. Suttle, G. M. Pollack and K. L. R. Brouwer, Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles. Pharm. Res., 9, 350-356 (1992). 79. R. Suverkrup, Discontinuous absorption processes in pharmacokinetic models. J. Pharm. Sci., 68, 1395 — 1400 (1979). 80. C. D. Klaassen and J. B. Watkins III, Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacological rev., 36, 1-67 (1984). 81. Y. Hashimoto, H. Sasa, M. Shimomura, and K. Inui, Effects of intestinal and hepatic metabolism on the bioavailability of tacrolimus in rats. Pharm. Res., 15, 1609 — 1613 (1998). 82. G. J. Mulder, Conjugation reactions in drug metabolism. Taylor & Francis Ltd, 1990, pp.41-49. 83. G. J. Mulder, Conjugation reactions in drug metabolism. Taylor & Francis Ltd, 1990, pp.51-105. 84. G. J. Mulder, Conjugation reactions in drug metabolism. Taylor & Francis Ltd, 1990, pp.107-161. 85. M. E. Morris, V. Yuen, B. K. Tang and K. S. Pang, Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation. J. Pharmacol. Exp. Ther., 245, 614 — 624 (1988). 86. K. W. Bock and D. Winne, Glucuronidation of 1-naphthol in the rat intestinal loop. Biochem. Pharmacol., 24, 859 — 862 (1975). 87. P. Wollenberg, V. Ullrich and W. Rummel, Conjugation of 1-naphthol and transport of 1-naphthol-conjugates in the vascularly perfused small intestine of the mouse. Biochem. Pharmacol., 32, 2103 — 2107 (1983). 88. G. J. Mulder, S. Brouwer and E. Scholtens, High-rate intestinal conjugation of 4-methyl-umbelliferone during intravenous infusion in the rat in vivo. Biochem. Pharmacol., 33, 2341 — 2344 (1984). 89. G. J. Mulder, S. Brouwer, J. G. Weitering, E. Scholtens and K. S. Pang, Glucuronidation and sulfation in the rat in vivo: The role of the liver and the intestine in the in vivo clearance of 4-methylumbelliferone. Biochem. Pharmacol., 34, 1325 — 1329 (1985). 90. A. SJ. Koster, A. C. Frankhuijzen-Sierevogel and J. Noordhoek, Distribution of glucuronidation capacity (1-naphthol and morphine) along the rat intestine. Biochem. Pharmacol., 34, 3527 — 3532 (1985). 91. J. Brès, F. Bressolle, Pharmacokinetics of sulpiride in human after intravenous and intramuscular administration. J. Pharm. Sci., 80, 1119 — 1122 (1991). 92. H. L. Fleuren and J. M. van Rossum, Nonlinear relationship between plasma and red blood cell pharmacokinetics of chlorthalidone in man. J. Pharmacokinet. Biopharm., 5, 359 — 375 (1977). 93. D. Kurata and G. R. Wilkinson, Ethrocyte uptake and plasma binding of diphenylhydantoin. Clin. Pharmacol. Ther., 16, 355 — 362 (1974). 94. C. I. Colino, A. G. Turino, A. S. Navarro and J. M. Lanao, A comparative study of ofloxacin and ciprofloxacin ethrocyte distribution. Bipharm. Drug Disposit., 19, 71 — 77 (1998). 95. M. Rowland and T. N. Tozer, Clinical pharmacokinetics: Concepts and applications, 3rd ed., Williams & Wilkins, 1995, pp.156 — 183. 96. T. Adzet, J. Camarasa, E. Escubedo and M. Merlos, In vitro study of caffeic acid-bovine serum albumin interaction. Eur J Drug Metab Pharmacokinet 13: 11- 14 (1988). 97. P.-C. Wang, N. T. Buu, O. Kuchel and J. Genest, Conjugation patterns of endogenous plasma catecholamines in human and rat. J. Lab. Clin. Med., 101, 141 — 151 (1983). 98. M. Oka, Y. Ishimura, T. Tsunematsu, K. Minakuchi, T. Ohuchi and K. Matsumoto, Effects of administration of dopamine and L-dopa to dogs on their plasma level of dopamine sulfate. Biochem. Pharmacol., 36, 3205 — 3208 (1987).
|